Skip to main content

IDEX Biometrics: Employee Share Purchase Plan – 1 Sep 2022

The board of directors of IDEX Biometrics ASA has resolved to issue 3,181,755 ordinary shares at NOK 0.73 per share to employees who participate in the company’s 2021 Employee Share Purchase Plan (ESPP). The ESPP was approved by the annual general meeting on 12 May 2021.

 

40 employees participated in the ESPP in this period. The participating employees have elected to invest a part of the base salary in ordinary shares in the company. Purchase takes place every six months.

 

Following the issue, the Company’s share capital will be NOK 152,412,062.55 divided into 1,016,080,417 shares, each with a nominal value of NOK 0.15.

 

Primary insiders

IDEX discloses transactions by the following primary insiders in IDEX shares ISIN NO0003070609:

–   CEO Vince Graziani acquired 133,565 ordinary shares at NOK 0,73 per share.

 

IDEX 2021 ESPP

The ESPP was approved at the annual general meeting on 12 May 2021. Reference is made to the notice of said meeting where the plan document for the ESPP was attached. 

 

All employees in the Company and its subsidiaries, except in China, have been offered to subscribe for shares in the Company in connection with the ESPP. The ESPP is structured around two contribution periods, starting on 1 September and 1 March and lasting for the following six months. During each contribution period, a fixed amount (up to 20% of the employee’s gross base salary) is withheld from the employee’s net salary each month. The employee may sign up to participate in the ESPP from the date of the public disclosure of the interim report before the contribution period until the beginning of the contribution period. Unless the employee actively withdraws from the ESPP, participation is automatically renewed for the same amount for subsequent contribution periods. The board’s resolution to issue new shares in connection with the ESPP is made pursuant to the authorization granted by the Company’s annual general meeting on 12 May 2021 to increase the Company’s share capital in connection with the ESPP.

 

In accordance with the ESPP, the subscription price is the lower closing price of the Company’s share, as traded on Oslo Børs, on the first or last day of the contribution period, less 15% discount. Payment of the subscription amount is made out of the relevant employee salary withholding.

 

In accordance with Regulation (EU) 2017/1129 (the “Prospectus Regulation”) Article 1 (5) h, issuance of shares in connection with the ESPP is exempt from the obligation to publish a listing prospectus.

 

For further information contact:

Marianne Bøe, Investor Relations

E-mail: marianne.boe@idexbiometrics.com

Tel: + 47 918 00186

 

Brett L. Perry, U.S. Investor Relations

E-mail: bperry@sheltongroup.com

Tel: +1 214 272 0070

 

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings. We invent, engineer, and commercialize these secure and safe yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

 

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.